P29375 (KDM5A_HUMAN) Homo sapiens (Human)
Lysine-specific demethylase 5A UniProtKBInterProSTRINGInteractive Modelling
1690 aa; Sequence (Fasta) ; (Isoform 2)
It is possible new templates exist for this target since these models were created.
Available Structures
46 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Solution structure of the PHD1 domain of histone demethylase KDM5A in complex with a histone H3(1-1… |
Heteromer P68431; | 100 | 2×ZN; | |||
| Crystal structure of JARID1A-PHD3 complexed with H3(1-9)K4me3 peptide |
Heteromer Q92133; | 100 | 6×ZN; | |||
| Crystal Structure of Jarid1a PHD finger bound to histone H3C4me3 peptide |
Heteromer P68431; | 100 | 2×ZN; | |||
| Crystal structure of KDM5A in complex with a naphthyridone inhibitor | homo-2-mer | 100.0 | 2×NI; 4×ZN; 2×6QN; | |||
| Crystal structure of pyrrolidine amide inhibitor [(3S)-3-(4-bromo-1H-pyrazol-1-yl)pyrrolidin-1-yl][… | monomer | 100.0 | 1×NI; 2×ZN; 1×90S; 1×SO4; | |||
| Crystal structure of selective pyrrolidine amide KDM5a inhibitor N-{(3R)-1-[3-(propan-2-yl)-1H-pyra… | monomer | 100.0 | 1×NI; 2×ZN; 1×90V; | |||
| Structure of histone lysine demethylase KDM5A in complex with selective inhibitor | monomer | 100.0 | 1×NI; 2×ZN; 1×50P; | |||
| LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR 2-((2-chlorophenyl)(2-(1-methylpyrrolidin-2-yl)ethox… | monomer | 100.0 | 1×DLJ; 1×MN; 4×EDO; 2×DMS; 1×GOL; | |||
| LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR GSK-J1 | monomer | 100.0 | 1×K0I; 1×MN; 5×GOL; 3×SO4; 2×DMS; | |||
| LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR (R)-N-(1-(3-isopropyl-1H-pyrazole-5-carbonyl)pyrroli… | monomer | 100.0 | 1×MN; 2×GOL; 1×90V; 5×EDO; | |||
| LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR N49 i.e. 2-((2-chlorophenyl)(2-(1-methylpyrrolidin-2… | monomer | 100.0 | 1×H6S; 1×H6T; 1×MN; 2×DMS; 1×SO4; 1×EDO; | |||
| LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR 2-((2-chlorophenyl)(2-(piperidin-1-yl)ethoxy)methyl)… | monomer | 100.0 | 1×DQG; 1×MN; 4×GOL; 2×DMS; 4×EDO; | |||
| LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR 2-((2-chlorophenyl)(2-(4,4-difluoropiperidin-1-yl)et… | monomer | 100.0 | 1×DKS; 1×MN; 5×GOL; 1×DMS; | |||
| LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR 2-((2-chlorophenyl)(propoxy)methyl)-1H-pyrrolo[3,2-b… | monomer | 100.0 | 1×DKP; 1×MN; 1×DMS; 2×GOL; 4×EDO; 1×SO4; | |||
| LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR 2-((2-chlorophenyl)(2-(1-methyl-1H-imidazol-2-yl)eth… | monomer | 100.0 | 1×DNV; 1×MN; 2×GOL; | |||
| LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR N68 i.e. 2-(1-(2-(piperidin-1-yl)ethyl)-1H-benzo[d]i… | monomer | 100.0 | 1×H61; 1×MN; | |||
| LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR N67 i.e. 2-(5-phenyl-4-(phenyl(2-(piperidin-1-yl)eth… | monomer | 100.0 | 1×H6A; 1×MN; 1×GOL; 3×DMS; | |||
| LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR (S)-N-(1-(3-isopropyl-1H-pyrazole-5-carbonyl)pyrroli… | monomer | 100.0 | 1×DQJ; 1×MN; 1×DMS; 2×GOL; 5×EDO; | |||
| Linked KDM5A JMJ Domain Bound to the Covalent Inhibitor N69 i.e. [2-((3-acrylamidophenyl)(2-(piperi… | monomer | 100.0 | 1×H74; 1×MN; 1×GOL; 2×DMS; 2×EDO; | |||
| LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR N50 i.e. 2-(4-((2-(dimethylamino)ethyl)(ethyl)carbam… | monomer | 100.0 | 1×H5Y; 1×MN; 1×DMS; 1×GOL; 1×SO4; | |||
| Linked KDM5A Jmj Domain Bound to the Inhibitor N8 ( 5-methyl-7-oxo-6-(propan-2-yl)-4,7-dihydropyraz… | monomer | 100.0 | 1×6E8; 1×MN; | |||
| LINKED KDM5A JMJ DOMAIN FORMING COVALENT BOND TO INHIBITOR N71 i.e. 2-((3-(4-(dimethylamino)but-2-e… | monomer | 100.0 | 1×H77; 1×HZV; 1×HZM; 1×MN; 2×GOL; 2×DMS; | |||
| LINKED KDM5A JMJ DOMAIN BOUND TO THE POTENTIAL HYDROLYSIS PRODUCT OF INHIBITOR N45 i.e. 3-((6-(4-(2… | monomer | 100.0 | 1×H6M; 1×MN; 1×EDO; 1×GOL; | |||
| Linked KDM5A JMJ Domain Bound to Inhibitor N70 i.e.[2-((3-aminophenyl)(2-(piperidin-1-yl)ethoxy)met… | monomer | 100.0 | 1×H6V; 1×MN; 2×GOL; 3×EDO; | |||
| LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR (S)-2-((2-chlorophenyl)(2-(piperidin-1-yl)ethoxy)met… | monomer | 100.0 | 1×DQG; 1×MN; 1×DMS; 2×EDO; | |||
| LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR (R)-2-((2-chlorophenyl)(2-(piperidin-1-yl)ethoxy)met… | monomer | 100.0 | 1×DO1; 1×MN; 1×DMS; | |||
| LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR 5-(1-(tert-butyl)-1H-pyrazol-4-yl)-6-isopropyl-7-oxo… | monomer | 100.0 | 1×DQS; 1×MN; 7×EDO; 1×GOL; | |||
| Linked KDM5A Jmj Domain Bound to the Inhibitor 2-(((2-((2-(dimethylamino)ethyl)(ethyl)amino)-2-oxoe… | monomer | 100.0 | 1×LQT; 1×MN; | |||
| A High Resolution Structure of a Linked KDM5A Jmj Domain with Alpha-Ketoglutarate | monomer | 100.0 | 1×AKG; 1×MN; 4×GOL; | |||
| Linked KDM5A Jmj Domain Bound to the Inhibitor N16 [3-(2-(4-chlorophenyl)acetamido)isonicotinic aci… | monomer | 100.0 | 1×6EO; 1×MN; | |||
| Linked KDM5A Jmj Domain Bound to the Inhibitor N11 [3-({1-[2-(4,4-difluoropiperidin-1-yl)ethyl]-5-f… | monomer | 100.0 | 1×6ED; 1×MN; 1×GOL; 1×DMS; | |||
| Linked KDM5A Jmj Domain Bound to the Inhibitor N3 (4'-[(2-phenylethyl)carbamoyl][2,2'-bipyridine]-4… | monomer | 100.0 | 1×6E7; 1×MN; 3×EDO; 1×GOL; | |||
| LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR N44 i.e. 3-((2-(pyridin-2-yl)-6-(4-(vinylsulfonyl)-1… | monomer | 100.0 | 1×H6J; 1×MN; 1×GOL; 1×DMS; | |||
| Linked KDM5A Jmj Domain Bound to the Inhibitor N19 [2-(5-((4-chloro-2-methylbenzyl)oxy)-1H-pyrazol-… | monomer | 100.0 | 1×6EP; 1×AKG; 1×MN; 2×EDO; 2×GOL; | |||
| LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR 2-((2-chlorophenyl)(3-(piperidin-1-yl)propoxy)methyl… | monomer | 100.0 | 1×DNY; 1×MN; 5×EDO; 1×GOL; | |||
| Linked KDM5A Jmj Domain Bound to the Inhibitor N10 8-(1-methyl-1H-imidazol-4-yl)-2-(4,4,4-trifluoro… | monomer | 100.0 | 1×6EB; 1×MN; | |||
| Linked KDM5A Jmj Domain Bound to the Inhibitor C49 (2-{[(2-{[(E)-2-(dimethylamino)ethenyl](ethyl)am… | monomer | 100.0 | 1×MMK; 1×MN; 1×GOL; 1×EDO; | |||
| Linked KDM5A Jmj Domain Bound to the Inhibitor N12 [3-((1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)amin… | monomer | 100.0 | 1×6EN; 1×MN; | |||
| LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR 2-((2-chlorophenyl)((4,4-difluorocyclohexyl)methoxy)… | monomer | 100.0 | 1×DKV; 1×MN; 2×GOL; 2×EDO; | |||
| LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR N53 i.e. 2-(5-([1,1'-biphenyl]-3-yl)-4-(1-(2-(piperi… | monomer | 100.0 | 1×H67; 1×MN; 2×GOL; 2×DMS; | |||
| A Linked Jumonji Domain of the KDM5A Lysine Demethylase | monomer | 100.0 | 1×MN; 1×AKG; 2×GOL; | |||
| LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR N43 i.e. 3-((6-(4-acryloyl-1,4-diazepan-1-yl)-2-(pyr… | monomer | 100.0 | 1×H6G; 1×MN; | |||
| NMR structure of the ARID domain from the histone H3K4 demethylase RBP2 | monomer | 100 | ||||
| Solution structure of the PHD1 domain of histone demethylase KDM5A | monomer | 100 | 2×ZN; | |||
| Solution Structure of JARID1A C-terminal PHD finger | monomer | 100 | 2×ZN; | |||
| Solution structure of JARID1A C-terminal PHD finger in complex with H3(1-9)K4me3 | monomer | 100 | 2×ZN; | |||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 5k4l.1.A | monomer | 0.66 | 1×NI; 2×ZN; 1×6QN; | 100.00 | ||
| 2e6r.1.A | monomer | 0.61 | 1×ZN; | 65.28 | ||
2 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 5k4l.1.A | monomer | 0.65 | 1×NI; 2×ZN; 1×6QN; | 100.00 | ||
| Isoform 2 | 2miq.1.A | monomer | 0.52 | 2×ZN; | 60.87 | ||